首页>投融资
PrognomiQ
D轮
PrognomIQ, a spin-out of Seer, is a healthcare company focused on the development and commercialization of multi-omics human tests for cancer and other diseases.In September 2020, Seer Inc announced that it has spun out and completed the initial financing of $55M for a newly formed healthcare company, PrognomIQ, Inc..In September 2021, Seer, Inc announced that it has spun out and completed the initial financing of $55M for PrognomIQ, Inc
基本信息
-
公司全称PrognomIQ Inc
-
类型早期疾病测试产品开发商
-
产业领域医药研发/制造、化学&生物药、医疗器械
-
公司人数15~50人
-
地址1900 Alameda de las Pulgas Suite 100 SAN MATEO CALIFORNIA 94403; US;
-
联系电话
-
邮箱info@prognomiq.com
-
成立时间2020-01-01
投融资
-
2024-11-05D轮3400万美元SeerCatalio Capital ManagementaMoonInvusBruker
-
2022-03-15未透露4600万美元Catalio Capital ManagementInvusMaverick CapitalaMoonEmerson CollectiveWing VenturesT. Rowe Price富达国际Bruker
-
2020-09-15未公开5500万美元aMoonWing VenturesEmerson CollectiveMaverick CapitalInvusT. Rowe Price富达国际
相关投融资企业
上市后再融资
Delcath Systems, Inc.于1988年8月在特拉华州公司注册成立。该公司是一个后期临床开发公司，致力于研究肝脏癌症，是一家专业制药和医疗器械公司，开发专利产品 - 美法仑注射用盐酸，用于Delcath肝输送系统（美法仑/ HDS）的使用。
D轮
PrognomIQ, a spin-out of Seer, is a healthcare company focused on the development and commercialization of multi-omics human tests for cancer and other diseases.In September 2020, Seer Inc announced that it has spun out and completed the initial financing of $55M for a newly formed healthcare company, PrognomIQ, Inc..In September 2021, Seer, Inc announced that it has spun out and completed the initial financing of $55M for PrognomIQ, Inc
增发
GE HealthCare Technologies Inc.于2022年5月16日作为特拉华州有限责任公司成立。根据重组，该公司将成为一家控股公司，其资产预计将包括通用电气公司（“GE”）旗下业务GE 医疗保健的所有未偿还股权。GE 医疗保健是全球领先的医疗技术、药物诊断和数字解决方案创新者。他们的产品、解决方案和服务涵盖患者护理的连续过程，包括筛查、诊断、治疗和监测，目标是使临床医生能够以更低的成本提供更好的护理。他们在全球拥有超过400万台医疗设备的安装基础，每年可实现超过20亿次手术，影响超过10亿患者。他们的补充药物诊断剂以每秒大约三名患者的速度用于成像程序。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息